Developer docs
API playgroundTry for free, no card

Search company profiles

Clinical Research Management

Full company profile

uuid0009d2c

Namestring
Clinical Research Management
Legal namestring
Clinical Research Management Inc.
Websiteurl
clinicalrm.com
Company typeenum
Private
Founded yearint
1992
Descriptiontext

Clinical Research Management Inc. (ClinicalRM) is a US-based, full-service Contract Research Organization (CRO) founded in 1992 and headquartered in Hinckley, Ohio. The company provided clinical trial management services — including study design, execution, monitoring, and operational delivery — to government-sponsored research programs, with a particular concentration in vaccines and infectious disease clinical trials. This narrow specialization in federal research (likely spanning NIH-, BARDA-, and DoD-adjacent sponsors) defined its value proposition and differentiated it from commercial biopharma-oriented CROs.

Its business model revolved around program-based contracts with US government sponsors; pricing, contract structures, and per-study economics are not publicly disclosed. The company operated privately with a workforce of 251-500 employees, supported a business development function (evidenced by a VP of Business Development role), and served a horizontal customer segment centered on government-sponsored research and infectious disease trials. Core technology and proprietary platforms are not publicly disclosed, and the differentiation rests on operational expertise, regulatory familiarity with federal clinical research frameworks, and accumulated sponsor relationships rather than on disclosed product or technology assets.

In February 2024, ClinicalRM was acquired by ICON plc (NASDAQ: ICLR), a publicly traded Irish-headquartered global CRO. The acquisition was explicitly framed as a strategic move to expand ICON's capabilities in government-sponsored research and vaccines/infectious disease trials, integrating ClinicalRM's specialized expertise into ICON's broader clinical research services portfolio. Following the acquisition, ClinicalRM no longer operates as an independent entity, and its standalone forward trajectory is a function of ICON's portfolio strategy rather than independent capital allocation.

Short descriptiontext

Clinical Research Management (ClinicalRM) is a US-based, full-service Contract Research Organization founded in 1992 and acquired by ICON plc in February 2024, specializing in clinical trial management for government-sponsored research and vaccines/infectious disease trials.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersHinckley, United States
HQ citystring
Hinckley
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
contract research organization, clinical trial management, government-sponsored research, vaccine clinical trials, infectious disease research
Industry2 codes
1Vaccine Clinical Development & Regulatory Affairs
CodeHLAIAEAMPrimaryYes
2Clinical Research & Trial Central Laboratories
CodeHLAFAMALPrimaryNo
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Medical and Diagnostic Laboratories62151
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Contract Research Organization (CRO) Services
Social media profiles3 records
Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Clinical Research Management (ClinicalRM) is a full-service Contract Research Organization that manages and conducts clinical trials for government-sponsored research programs, with specialized expertise in vaccines and infectious disease trials. The company provides end-to-end clinical trial support services from study design through execution for public-sector and biopharmaceutical sponsors.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Based on the available source data, there is insufficient information to provide a detailed product overview for Clinical Research Management. The only reference indicates that ICON plc acquired Clinical Research Management Inc. in February 2024 to expand its capabilities in government-sponsored research and vaccines and infectious disease trials.

Product and service2 records
1Clinical Trial Management Services
CategoryContract Research Services
2Government-Sponsored Research Support
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-02-01
Description

In February 2024, ICON plc acquired US-based Clinical Research Management Inc. to expand its capabilities in government-sponsored research and vaccines and infectious disease trials. This acquisition represents a strategic integration of CRM's specialized expertise into ICON plc's broader clinical research services portfolio.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers6 records
TypeDirect peer
TypeBroad incumbent
Description

ICON plc is a global tier-1 CRO that acquired Clinical Research Management in February 2024. As the parent and acquirer, it is the most direct comparator for CRM's full-service clinical trial management capabilities and government/vaccine trial focus.

TypeBroad incumbent
Description

IQVIA is the largest global CRO and life sciences technology provider. It competes with CRM for large government and biopharma clinical trial programs and operates across the same full-service CRO category, including vaccine and infectious disease work.

TypeBroad incumbent
Description

Thermo Fisher acquired PPD in 2021, making it one of the largest global CROs. PPD competes directly with CRM in clinical trial management for vaccines, infectious disease, and government-sponsored programs at global scale.

TypeBroad incumbent
Description

Charles River is a major CRO and preclinical services provider with a strong vaccine and infectious disease research portfolio. It overlaps with CRM's vaccine and infectious disease trial focus and competes for government biodefense research contracts.

TypeBroad incumbent
Description

Parexel is a tier-1 global CRO offering full-service clinical development across therapeutic areas including infectious disease and vaccines. Its scale and government/biopharma client base make it a direct competitor to CRM in mid-to-large clinical trial programs.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Clinical Research Management

Contract Research Organization (CRO) Servicesclinicalrm.com

Clinical Research Management (ClinicalRM) is a US-based, full-service Contract Research Organization founded in 1992 and acquired by ICON plc in February 2024, specializing in clinical trial management for government-sponsored research and vaccines/infectious disease trials.

What Clinical Research Management does

Clinical Research Management Inc. (ClinicalRM) is a US-based, full-service Contract Research Organization (CRO) founded in 1992 and headquartered in Hinckley, Ohio. The company provided clinical trial management services — including study design, execution, monitoring, and operational delivery — to government-sponsored research programs, with a particular concentration in vaccines and infectious disease clinical trials. This narrow specialization in federal research (likely spanning NIH-, BARDA-, and DoD-adjacent sponsors) defined its value proposition and differentiated it from commercial biopharma-oriented CROs.

Its business model revolved around program-based contracts with US government sponsors; pricing, contract structures, and per-study economics are not publicly disclosed. The company operated privately with a workforce of 251-500 employees, supported a business development function (evidenced by a VP of Business Development role), and served a horizontal customer segment centered on government-sponsored research and infectious disease trials. Core technology and proprietary platforms are not publicly disclosed, and the differentiation rests on operational expertise, regulatory familiarity with federal clinical research frameworks, and accumulated sponsor relationships rather than on disclosed product or technology assets.

In February 2024, ClinicalRM was acquired by ICON plc (NASDAQ: ICLR), a publicly traded Irish-headquartered global CRO. The acquisition was explicitly framed as a strategic move to expand ICON's capabilities in government-sponsored research and vaccines/infectious disease trials, integrating ClinicalRM's specialized expertise into ICON's broader clinical research services portfolio. Following the acquisition, ClinicalRM no longer operates as an independent entity, and its standalone forward trajectory is a function of ICON's portfolio strategy rather than independent capital allocation.

Clinical Research Management firmographics

Firmographics
Name
Clinical Research Management
Legal name
Clinical Research Management Inc.
Website
https://clinicalrm.com
Company type
Private
Founded year
1992
Operating status
Acquired
Headcount range
251–500 employees
Short description
Clinical Research Management (ClinicalRM) is a US-based, full-service Contract Research Organization founded in 1992 and acquired by ICON plc in February 2024, specializing in clinical trial management for government-sponsored research and vaccines/infectious disease trials.
Ownership category
akta.pro rank

Clinical Research Management industry classification

Industry
Product category
Contract Research Organization (CRO) Services
NAICS
Scientific Research and Development Services (5417), Medical and Diagnostic Laboratories (62151)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Vaccine Clinical Development & Regulatory Affairs (HLAIAEAM)
akta.pro secondary industry
Clinical Research & Trial Central Laboratories (HLAFAMAL)

Keywords

  • Contract research organization
  • Clinical trial management
  • Government-sponsored research
  • Vaccine clinical trials
  • Infectious disease research

Where Clinical Research Management is headquartered

Location

Headquarters

HQ city
Hinckley
HQ country
United States
HQ region
North America

Markets served

Clinical Research Management business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Clinical Research Management product offering

Product offering

Core offering

Clinical Research Management (ClinicalRM) is a full-service Contract Research Organization that manages and conducts clinical trials for government-sponsored research programs, with specialized expertise in vaccines and infectious disease trials. The company provides end-to-end clinical trial support services from study design through execution for public-sector and biopharmaceutical sponsors.

Product overview

Based on the available source data, there is insufficient information to provide a detailed product overview for Clinical Research Management. The only reference indicates that ICON plc acquired Clinical Research Management Inc. in February 2024 to expand its capabilities in government-sponsored research and vaccines and infectious disease trials.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Trial Management Services
  • Government-Sponsored Research Support

Companies that use Clinical Research Management

Customer profile

Segments2 records

Ideal customer profiles2 records

Clinical Research Management technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Clinical Research Management partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • ICON plccoreStrategic or Co-development Partner · 1 February 2024In February 2024, ICON plc acquired US-based Clinical Research Management Inc. to expand its capabilities in government-sponsored research and vaccines and infectious disease trials. This acquisition represents a strategic integration of CRM's specialized expertise into ICON plc's broader clinical research services portfolio.

Scale indicators1 record

Recent moves1 record

Expansion highlights3 records

Clinical Research Management competitors and assessment

Company assessment

Direct peers

Broad incumbents

  • ICON plc: ICON plc is a global tier-1 CRO that acquired Clinical Research Management in February 2024. As the parent and acquirer, it is the most direct comparator for CRM's full-service clinical trial management capabilities and government/vaccine trial focus.
  • IQVIA: IQVIA is the largest global CRO and life sciences technology provider. It competes with CRM for large government and biopharma clinical trial programs and operates across the same full-service CRO category, including vaccine and infectious disease work.
  • Thermo Fisher Scientific (PPD): Thermo Fisher acquired PPD in 2021, making it one of the largest global CROs. PPD competes directly with CRM in clinical trial management for vaccines, infectious disease, and government-sponsored programs at global scale.
  • Charles River Laboratories: Charles River is a major CRO and preclinical services provider with a strong vaccine and infectious disease research portfolio. It overlaps with CRM's vaccine and infectious disease trial focus and competes for government biodefense research contracts.
  • Parexel International: Parexel is a tier-1 global CRO offering full-service clinical development across therapeutic areas including infectious disease and vaccines. Its scale and government/biopharma client base make it a direct competitor to CRM in mid-to-large clinical trial programs.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Clinical Research Management social profiles

Digital presence

Clinical Research Management financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Clinical Research Management leadership team

Management profile

Number of profiles

Profiles1 record

Clinical Research Management funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Clinical Research Management M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinical Research Management

What does Clinical Research Management do?

Clinical Research Management (ClinicalRM) is a full-service Contract Research Organization that manages and conducts clinical trials for government-sponsored research programs, with specialized expertise in vaccines and infectious disease trials. The company provides end-to-end clinical trial support services from study design through execution for public-sector and biopharmaceutical sponsors.

Is Clinical Research Management a public or private company?

Clinical Research Management is a private company. It is classified as corporate owned and is currently acquired.

When was Clinical Research Management founded?

Clinical Research Management was founded in 1992. It employs 251 to 500 people.

Where is Clinical Research Management based?

Clinical Research Management is headquartered in Hinckley, United States, in the North America region.

Who are Clinical Research Management's main competitors?

Medpace Holdings is listed as a direct peer. Broad incumbents are ICON plc, IQVIA, Thermo Fisher Scientific (PPD), Charles River Laboratories and Parexel International.

Does Clinical Research Management have an API?

No public API is recorded for Clinical Research Management.

What industry is Clinical Research Management in?

Clinical Research Management's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAIAEAM, Vaccine Clinical Development & Regulatory Affairs, with a secondary code of HLAFAMAL, Clinical Research & Trial Central Laboratories. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals